{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T17:08:56Z","timestamp":1790096936215,"version":"4.0.1"},"reference-count":98,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 CA293210"],"award-info":[{"award-number":["R01 CA293210"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000009","name":"Foundation for the National Institutes of Health","doi-asserted-by":"publisher","award":["R01 CA293210"],"award-info":[{"award-number":["R01 CA293210"]}],"id":[{"id":"10.13039\/100000009","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Discovery Today"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.drudis.2026.104764","type":"journal-article","created":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T16:27:35Z","timestamp":1786465655000},"page":"104764","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Targeting chemobrain: from experimental models to therapeutic discovery"],"prefix":"10.1016","volume":"31","author":[{"given":"Nishant N.","family":"Parikh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyung-Goo","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amelia Michelle Sojung","family":"Moon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sang Hoon","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sang Hoon","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Euiyeon","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Abdur","family":"Rashid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongkyu","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"X.F. Steven","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mi-Hyeon","family":"Jang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.drudis.2026.104764_b0005","unstructured":"Institute NC. Cancer Statistics. https:\/\/www.cancer.gov\/about-cancer\/understanding\/statistics."},{"key":"10.1016\/j.drudis.2026.104764_b0010","doi-asserted-by":"crossref","first-page":"102","DOI":"10.3109\/09540261.2013.864260","article-title":"Prevalence, mechanisms, and management of cancer-related cognitive impairment","volume":"26","author":"Janelsins","year":"2014","journal-title":"Int Rev Psychiatry"},{"key":"10.1016\/j.drudis.2026.104764_b0015","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1037\/neu0000064","article-title":"A meta-analysis of cognitive impairment following adult cancer chemotherapy","volume":"28","author":"Lindner","year":"2014","journal-title":"Neuropsychology"},{"key":"10.1016\/j.drudis.2026.104764_b0260","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1200\/JCO.2011.37.0189","article-title":"Neuropsychological performance in survivors of breast cancer more than 20 years after adjuvant chemotherapy","volume":"30","author":"Koppelmans","year":"2012","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.drudis.2026.104764_b0020","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.soncn.2013.08.006","article-title":"Proposed mechanisms for cancer- and treatment-related cognitive changes","volume":"29","author":"Merriman","year":"2013","journal-title":"Semin Oncol Nurs"},{"key":"10.1016\/j.drudis.2026.104764_b0025","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2025.1662935","article-title":"Mapping self-awareness of cancer-related cognitive impairment: a scoping review of evidence, methods, and neurobiological correlates","volume":"16","author":"Spinetti","year":"2025","journal-title":"Front Neurol"},{"key":"10.1016\/j.drudis.2026.104764_b0030","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.neubiorev.2019.05.001","article-title":"Chemotherapy-induced cognitive impairments: a systematic review of the animal literature","volume":"102","author":"Matsos","year":"2019","journal-title":"Neurosci Biobehav Rev"},{"key":"10.1016\/j.drudis.2026.104764_b0035","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.pbb.2010.08.019","article-title":"Single high dose treatment with methotrexate causes long-lasting cognitive dysfunction in laboratory rodents","volume":"97","author":"Fardell","year":"2010","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.drudis.2026.104764_b0040","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.pbb.2006.07.010","article-title":"The effects of the anti-cancer drugs, methotrexate and 5-fluorouracil, on cognitive function in mice","volume":"85","author":"Winocur","year":"2006","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.drudis.2026.104764_b0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.neubiorev.2025.106131","article-title":"Meta-analyses of executive function deficits in chemotherapy-treated rodent models","volume":"173","author":"Chen","year":"2025","journal-title":"Neurosci Biobehav Rev"},{"key":"10.1016\/j.drudis.2026.104764_b0050","doi-asserted-by":"crossref","first-page":"19290","DOI":"10.1038\/s41598-023-46616-9","article-title":"A Drosophila model relevant to chemotherapy-related cognitive impairment","volume":"13","author":"Torre","year":"2023","journal-title":"Sci Rep"},{"key":"10.1016\/j.drudis.2026.104764_b0055","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1002\/cphc.201701357","article-title":"Electrochemical measurement of dopamine release and uptake in zebrafish following treatment with carboplatin","volume":"19","author":"Field","year":"2018","journal-title":"ChemPhysChem"},{"key":"10.1016\/j.drudis.2026.104764_b0060","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1177\/0960327114521046","article-title":"Behavioral changes of zebrafish according to cisplatin-induced toxicity of the balance system","volume":"33","author":"Kim","year":"2014","journal-title":"Hum Exp Toxicol"},{"key":"10.1016\/j.drudis.2026.104764_b0065","doi-asserted-by":"crossref","first-page":"311","DOI":"10.2131\/jts.48.311","article-title":"Evaluation of neurotoxicity of anticancer drugs using nematode Caenorhabditis elegans as a model organism","volume":"48","author":"Sakaguchi","year":"2023","journal-title":"J Toxicol Sci"},{"key":"10.1016\/j.drudis.2026.104764_b0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbamcr.2023.119591","article-title":"Cisplatin-induced DNA crosslinks trigger neurotoxicity in C. elegans","volume":"1871","author":"Wynen","year":"2024","journal-title":"Biochim Biophys Acta Mol Cell Res"},{"key":"10.1016\/j.drudis.2026.104764_b0075","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1523\/JNEUROSCI.0353-18.2018","article-title":"Adverse effects of aromatase inhibition on the brain and behavior in a nonhuman primate","volume":"39","author":"Gervais","year":"2019","journal-title":"J Neurosci"},{"key":"10.1016\/j.drudis.2026.104764_b0080","doi-asserted-by":"crossref","DOI":"10.1002\/ajp.23271","article-title":"The marmoset as an important primate model for longitudinal studies of neurocognitive aging","volume":"83","author":"Rothwell","year":"2021","journal-title":"Am J Primatol"},{"key":"10.1016\/j.drudis.2026.104764_b0085","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.cell.2018.09.035","article-title":"A paradigm shift in cancer immunotherapy: from enhancement to normalization","volume":"175","author":"Sanmamed","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.drudis.2026.104764_b0090","article-title":"Systemic and targeted activation of Nrf2 reverses doxorubicin-induced cognitive impairments and sensorimotor deficits in mice","author":"Singh","year":"2024","journal-title":"bioRxiv"},{"key":"10.1016\/j.drudis.2026.104764_b9010","doi-asserted-by":"crossref","DOI":"10.1155\/jt\/4609428","article-title":"Herbo-Mineral Medicine, Cardiogrit Gold, Exhibits Protective Effects in Caenorhabditis elegans Model of Doxorubicin-Induced Cardiotoxicity","volume":"2025","author":"Balkrishna","year":"2025","journal-title":"J Toxicol."},{"key":"10.1016\/j.drudis.2026.104764_b0095","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1016\/j.freeradbiomed.2011.07.020","article-title":"Increased life span from overexpression of superoxide dismutase in Caenorhabditis elegans is not caused by decreased oxidative damage","volume":"51","author":"Cabreiro","year":"2011","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.drudis.2026.104764_b0100","doi-asserted-by":"crossref","first-page":"36026","DOI":"10.1038\/srep36026","article-title":"A novel approach using C. elegans DNA damage-induced apoptosis to characterize the dynamics of uptake transporters for therapeutic drug discoveries","volume":"6","author":"Papaluca","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.drudis.2026.104764_b0105","doi-asserted-by":"crossref","first-page":"e65","DOI":"10.1002\/cpmb.65","article-title":"RNAi screening: automated high-throughput liquid RNAi Screening in Caenorhabditis elegans","volume":"124","author":"Jagadeesan","year":"2018","journal-title":"Curr Protoc Mol Biol"},{"key":"10.1016\/j.drudis.2026.104764_b0110","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0250381","article-title":"The number of neurons in Drosophila and mosquito brains","volume":"16","author":"Raji","year":"2021","journal-title":"PLoS One"},{"key":"10.1016\/j.drudis.2026.104764_b0115","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.nbd.2011.03.022","article-title":"Drosophila melanogaster: a new model to study cisplatin-induced neurotoxicity","volume":"43","author":"Podratz","year":"2011","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.drudis.2026.104764_b0120","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.tins.2014.02.011","article-title":"Zebrafish models for translational neuroscience research: from tank to bedside","volume":"37","author":"Stewart","year":"2014","journal-title":"Trends Neurosci"},{"key":"10.1016\/j.drudis.2026.104764_b0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.expneurol.2019.113090","article-title":"Analyzing chemotherapy-induced peripheral neuropathy in vivo using non-mammalian animal models","volume":"323","author":"Cirrincione","year":"2020","journal-title":"Exp Neurol"},{"key":"10.1016\/j.drudis.2026.104764_b0135","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.bbr.2007.08.004","article-title":"Long-lasting suppression of hippocampal cell proliferation and impaired cognitive performance by methotrexate in the rat","volume":"186","author":"Seigers","year":"2008","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.drudis.2026.104764_b0140","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.neuroscience.2019.01.024","article-title":"Methotrexate affects cerebrospinal fluid folate and tau levels and induces late cognitive deficits in mice","volume":"404","author":"Elens","year":"2019","journal-title":"Neuroscience"},{"key":"10.1016\/j.drudis.2026.104764_b0145","doi-asserted-by":"crossref","DOI":"10.3390\/nu11040936","article-title":"Hesperidin alleviates methotrexate-induced memory deficits via hippocampal neurogenesis in adult rats","volume":"11","author":"Naewla","year":"2019","journal-title":"Nutrients"},{"key":"10.1016\/j.drudis.2026.104764_b0150","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1093\/neuonc\/noaa086","article-title":"Long-term clinically relevant rodent model of methotrexate-induced cognitive impairment","volume":"22","author":"Berlin","year":"2020","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.drudis.2026.104764_b0155","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2023.1212791","article-title":"Physiological and cognitive changes after treatments of cyclophosphamide, methotrexate, and fluorouracil: implications of the gut microbiome and depressive-like behavior","volume":"17","author":"Corley","year":"2023","journal-title":"Front Neurosci"},{"key":"10.1016\/j.drudis.2026.104764_b0160","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.bbr.2014.12.028","article-title":"Memory loss in chemotherapy-treated rats is exacerbated in high-interference conditions and related to suppression of hippocampal neurogenesis","volume":"281","author":"Winocur","year":"2015","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.drudis.2026.104764_b0165","doi-asserted-by":"crossref","first-page":"4446","DOI":"10.1158\/1078-0432.CCR-13-1179","article-title":"Memantine protects rats treated with intrathecal methotrexate from developing spatial memory deficits","volume":"19","author":"Cole","year":"2013","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.drudis.2026.104764_b0170","first-page":"29","article-title":"Investigation of the potential beneficial effects of fish oil against methotrexate-induced brain injury","author":"Kaya","year":"2022","journal-title":"Annal Med Res"},{"key":"10.1016\/j.drudis.2026.104764_b0175","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1002\/ana.410250408","article-title":"High-dose leucovorin reverses acute high-dose methotrexate neurotoxicity in the rat","volume":"25","author":"Phillips","year":"1989","journal-title":"Ann Neurol"},{"key":"10.1016\/j.drudis.2026.104764_b0180","doi-asserted-by":"crossref","first-page":"2311","DOI":"10.1007\/s00213-013-3394-0","article-title":"Physical exercise prevents suppression of hippocampal neurogenesis and reduces cognitive impairment in chemotherapy-treated rats","volume":"231","author":"Winocur","year":"2014","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.drudis.2026.104764_b0185","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.673340","article-title":"Doxorubicin-induced cognitive impairment: the mechanistic insights","volume":"11","author":"Du","year":"2021","journal-title":"Front Oncol"},{"key":"10.1016\/j.drudis.2026.104764_b0190","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s00213-014-3636-9","article-title":"Cognitive impact of cytotoxic agents in mice","volume":"232","author":"Seigers","year":"2015","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.drudis.2026.104764_b0195","article-title":"Dose-dependent cognitive decline, anxiety, and locomotor impairments induced by doxorubicin: evidence from an animal model","volume":"13","author":"Amaro-Leal","year":"2024","journal-title":"Biology (Basel)"},{"key":"10.1016\/j.drudis.2026.104764_b0200","doi-asserted-by":"crossref","DOI":"10.3390\/brainsci10030152","article-title":"Effect of metformin on doxorubicin-induced memory dysfunction","volume":"10","author":"Alharbi","year":"2020","journal-title":"Brain Sci"},{"key":"10.1016\/j.drudis.2026.104764_b0205","doi-asserted-by":"crossref","first-page":"603","DOI":"10.7150\/thno.67410","article-title":"HDAC6 inhibition reverses long-term doxorubicin-induced cognitive dysfunction by restoring microglia homeostasis and synaptic integrity","volume":"12","author":"McAlpin","year":"2022","journal-title":"Theranostics"},{"key":"10.1016\/j.drudis.2026.104764_b0210","doi-asserted-by":"crossref","first-page":"30324","DOI":"10.18632\/oncotarget.25718","article-title":"Doxorubicin-induced elevated oxidative stress and neurochemical alterations in brain and cognitive decline: protection by MESNA and insights into mechanisms of chemotherapy-induced cognitive impairment (\u201cchemobrain\u201d)","volume":"9","author":"Keeney","year":"2018","journal-title":"Oncotarget"},{"key":"10.1016\/j.drudis.2026.104764_b0215","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.bbr.2007.04.003","article-title":"Cancer chemotherapy impairs contextual but not cue-specific fear memory","volume":"181","author":"Macleod","year":"2007","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.drudis.2026.104764_b0220","doi-asserted-by":"crossref","DOI":"10.1016\/j.expneurol.2023.114609","article-title":"The chemotherapeutic agent doxorubicin induces brain senescence, with modulation by APOE genotype","volume":"371","author":"Demby","year":"2024","journal-title":"Exp Neurol"},{"key":"10.1016\/j.drudis.2026.104764_b0225","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0301379","article-title":"Doxorubicin causes cachexia, sarcopenia, and frailty characteristics in mice","volume":"19","author":"Cella","year":"2024","journal-title":"PLoS One"},{"key":"10.1016\/j.drudis.2026.104764_b0230","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.neuropharm.2018.02.013","article-title":"Physical exercise prevents cognitive impairment by enhancing hippocampal neuroplasticity and mitochondrial function in doxorubicin-induced chemobrain","volume":"133","author":"Park","year":"2018","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.drudis.2026.104764_b0270","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22041975","article-title":"The role of nucleotide excision repair in cisplatin-induced peripheral neuropathy: mechanism, prevention, and treatment","volume":"22","author":"Acklin","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.drudis.2026.104764_b0235","article-title":"Metformin prevents cisplatin-induced cognitive impairment and brain damage in mice","volume":"11","author":"Zhou","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.drudis.2026.104764_b0240","doi-asserted-by":"crossref","first-page":"17400","DOI":"10.1038\/s41598-018-35919-x","article-title":"Cisplatin treatment induces attention deficits and impairs synaptic integrity in the prefrontal cortex in mice","volume":"8","author":"Huo","year":"2018","journal-title":"Sci Rep"},{"key":"10.1016\/j.drudis.2026.104764_b0245","doi-asserted-by":"crossref","first-page":"3835","DOI":"10.1007\/s11357-025-01569-x","article-title":"Persisting blood-brain barrier disruption following cisplatin treatment in a mouse model of chemotherapy-associated cognitive impairment","volume":"47","author":"Patai","year":"2025","journal-title":"Geroscience"},{"key":"10.1016\/j.drudis.2026.104764_b0250","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2025.1592511","article-title":"Cisplatin induces hippocampal neurotoxicity and cognitive impairment in rats through neuroinflammation, oxidative stress, and overexpression of glutamatergic receptors mRNA","volume":"16","author":"Alhowail","year":"2025","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.drudis.2026.104764_b0255","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1093\/neuonc\/noaa151","article-title":"Cisplatin-induced peripheral neuropathy is associated with neuronal senescence-like response","volume":"23","author":"Calls","year":"2021","journal-title":"Neuro Oncol"},{"issue":"3","key":"10.1016\/j.drudis.2026.104764_b9005","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1158\/0008-5472.CAN-16-1817","article-title":"Pifithrin-\u03bc Prevents Cisplatin-Induced Chemobrain by Preserving Neuronal Mitochondrial Function","volume":"77","author":"Chiu","year":"2017","journal-title":"Cancer Res"},{"issue":"1","key":"10.1016\/j.drudis.2026.104764_b9000","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.critrevonc.2013.04.002","article-title":"Late effects of adjuvant chemotherapy for adult onset non-CNS cancer; cognitive impairment, brain structure and risk of dementia","volume":"88","author":"Koppelmans","year":"2013","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1016\/j.drudis.2026.104764_b0265","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.114238","article-title":"Vildagliptin restores cognitive function and mitigates hippocampal neuronal apoptosis in cisplatin-induced chemo-brain: imperative roles of AMPK\/Akt\/CREB\/ BDNF signaling cascades","volume":"159","author":"Mahmoud","year":"2023","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.drudis.2026.104764_b0275","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.physbeh.2015.10.031","article-title":"Hindbrain GLP-1 receptor mediation of cisplatin-induced anorexia and nausea","volume":"153","author":"De Jonghe","year":"2016","journal-title":"Physiol Behav"},{"key":"10.1016\/j.drudis.2026.104764_b0280","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2023.106680","article-title":"Liraglutide abrogates nephrotoxic effects of chemotherapies","volume":"189","author":"Xu","year":"2023","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.drudis.2026.104764_b0285","doi-asserted-by":"crossref","first-page":"2669","DOI":"10.1038\/bjc.2014.222","article-title":"Oral co-administration of elacridar and ritonavir enhances plasma levels of oral paclitaxel and docetaxel without affecting relative brain accumulation","volume":"110","author":"Hendrikx","year":"2014","journal-title":"Br J Cancer"},{"key":"10.1016\/j.drudis.2026.104764_b0290","doi-asserted-by":"crossref","DOI":"10.3390\/toxics9100229","article-title":"Pathomechanisms of paclitaxel-induced peripheral neuropathy","volume":"9","author":"Klein","year":"2021","journal-title":"Toxics"},{"key":"10.1016\/j.drudis.2026.104764_b0295","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/s13024-021-00463-2","article-title":"Pharmacological rescue of cognitive function in a mouse model of chemobrain","volume":"16","author":"Nguyen","year":"2021","journal-title":"Mol Neurodegener"},{"key":"10.1016\/j.drudis.2026.104764_b0300","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2025.1684006","article-title":"Paclitaxel-induced cognitive impairment: mechanistic insights","volume":"16","author":"Alhowail","year":"2025","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.drudis.2026.104764_b0130","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.bbi.2022.12.004","article-title":"Microglia are implicated in the development of paclitaxel chemotherapy-associated cognitive impairment in female mice","volume":"108","author":"Grant","year":"2023","journal-title":"Brain Behav Immun"},{"key":"10.1016\/j.drudis.2026.104764_b0305","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.nlm.2017.08.001","article-title":"The chemotherapeutic agent paclitaxel selectively impairs reversal learning while sparing prior learning, new learning and episodic memory","volume":"144","author":"Panoz-Brown","year":"2017","journal-title":"Neurobiol Learn Mem"},{"key":"10.1016\/j.drudis.2026.104764_b0310","doi-asserted-by":"crossref","DOI":"10.1111\/acel.13832","article-title":"Accelerated cerebromicrovascular senescence contributes to cognitive decline in a mouse model of paclitaxel (Taxol)-induced chemobrain","volume":"22","author":"Ahire","year":"2023","journal-title":"Aging Cell"},{"key":"10.1016\/j.drudis.2026.104764_b0315","doi-asserted-by":"crossref","first-page":"e1185","DOI":"10.1038\/tp.2017.149","article-title":"A novel preventive therapy for paclitaxel-induced cognitive deficits: preclinical evidence from C57BL\/6 mice","volume":"7","author":"Huehnchen","year":"2017","journal-title":"Transl Psychiatry"},{"key":"10.1016\/j.drudis.2026.104764_b0320","doi-asserted-by":"crossref","DOI":"10.1016\/j.ynpai.2019.100035","article-title":"Voluntary exercise reduces both chemotherapy-induced neuropathic nociception and deficits in hippocampal cellular proliferation in a mouse model of paclitaxel-induced peripheral neuropathy","volume":"6","author":"Slivicki","year":"2019","journal-title":"Neurobiol Pain"},{"key":"10.1016\/j.drudis.2026.104764_b0325","doi-asserted-by":"crossref","first-page":"3283","DOI":"10.1200\/JCO.20.03514","article-title":"Physical activity patterns and relationships with cognitive function in patients with breast cancer before, during, and after chemotherapy in a prospective, nationwide study","volume":"39","author":"Salerno","year":"2021","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.drudis.2026.104764_b0330","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1177\/10781552251324896","article-title":"Recent developments on checkpoint inhibitors, CAR T cells, and beyond for T cell-based immunotherapeutic strategies against cancer","volume":"31","author":"Ali","year":"2025","journal-title":"J Oncol Pharm Pract"},{"key":"10.1016\/j.drudis.2026.104764_b0335","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines12092158","article-title":"Revolutionizing cancer treatment: recent advances in immunotherapy","volume":"12","author":"Ghemrawi","year":"2024","journal-title":"Biomedicines"},{"key":"10.1016\/j.drudis.2026.104764_b0340","doi-asserted-by":"crossref","first-page":"3238","DOI":"10.1016\/j.cell.2025.03.041","article-title":"Immunotherapy-related cognitive impairment after CAR T cell therapy in mice","volume":"188","author":"Geraghty","year":"2025","journal-title":"Cell"},{"key":"10.1016\/j.drudis.2026.104764_b0345","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1186\/s13046-025-03442-3","article-title":"Immune checkpoint inhibition perturbs neuro-immune homeostasis and impairs cognitive function","volume":"44","author":"Ifejeokwu","year":"2025","journal-title":"J Exp Clin Cancer Res"},{"key":"10.1016\/j.drudis.2026.104764_b0350","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines11092516","article-title":"Update on nonhuman primate models of brain disease and related research tools","volume":"11","author":"Qiao","year":"2023","journal-title":"Biomedicines"},{"key":"10.1016\/j.drudis.2026.104764_b0355","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1667\/RR2497.1","article-title":"A model for assessing cognitive impairment after fractionated whole-brain irradiation in nonhuman primates","volume":"175","author":"Robbins","year":"2011","journal-title":"Radiat Res"},{"key":"10.1016\/j.drudis.2026.104764_b0360","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1093\/ilar\/ilw034","article-title":"Drug discovery in fish, flies, and worms","volume":"57","author":"Strange","year":"2016","journal-title":"ILAR J"},{"key":"10.1016\/j.drudis.2026.104764_b0365","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1093\/brain\/awq386","article-title":"Fumaric acid esters exert neuroprotective effects in neuroinflammation via activation of the Nrf2 antioxidant pathway","volume":"134","author":"Linker","year":"2011","journal-title":"Brain"},{"key":"10.1016\/j.drudis.2026.104764_b0370","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1159\/000512117","article-title":"N-acetylcysteine attenuates the anxiety-like behavior and spatial cognition impairment induced by doxorubicin and cyclophosphamide combination treatment in rats","volume":"106","author":"Kitamura","year":"2021","journal-title":"Pharmacology"},{"key":"10.1016\/j.drudis.2026.104764_b0375","doi-asserted-by":"crossref","first-page":"3727","DOI":"10.1158\/0008-5472.CAN-20-3290","article-title":"Nicotinamide mononucleotide prevents cisplatin-induced cognitive impairments","volume":"81","author":"Yoo","year":"2021","journal-title":"Cancer Res"},{"key":"10.1016\/j.drudis.2026.104764_b0380","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1038\/nrc3340","article-title":"The NAD metabolome\u2013a key determinant of cancer cell biology","volume":"12","author":"Chiarugi","year":"2012","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.drudis.2026.104764_b0385","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2026.218334","article-title":"Vitamin B3 derivatives support pancreatic cancer cell survival and chemotherapy resistance","volume":"645","author":"Nakazzi","year":"2026","journal-title":"Cancer Lett"},{"key":"10.1016\/j.drudis.2026.104764_b0390","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1038\/s41580-024-00752-w","article-title":"Regulation of and challenges in targeting NAD(+) metabolism","volume":"25","author":"Migaud","year":"2024","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.drudis.2026.104764_b0395","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2206415119","article-title":"Adenosine A(2A) receptor blockade prevents cisplatin-induced impairments in neurogenesis and cognitive function","volume":"119","author":"Oliveros","year":"2022","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.drudis.2026.104764_b0400","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s40478-022-01315-w","article-title":"Targeting the A(3) adenosine receptor to prevent and reverse chemotherapy-induced neurotoxicities in mice","volume":"10","author":"Singh","year":"2022","journal-title":"Acta Neuropathol Commun"},{"key":"10.1016\/j.drudis.2026.104764_b0405","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2023.1295991","article-title":"The selective cyclooxygenase-2 inhibitor NS398 ameliorates cisplatin-induced impairments in mitochondrial and cognitive function","volume":"16","author":"Rashid","year":"2023","journal-title":"Front Mol Neurosci"},{"key":"10.1016\/j.drudis.2026.104764_b0410","doi-asserted-by":"crossref","first-page":"2967","DOI":"10.1523\/JNEUROSCI.5552-09.2010","article-title":"NAD+ depletion is necessary and sufficient for poly(ADP-ribose) polymerase-1-mediated neuronal death","volume":"30","author":"Alano","year":"2010","journal-title":"J Neurosci"},{"key":"10.1016\/j.drudis.2026.104764_b0415","doi-asserted-by":"crossref","first-page":"2584","DOI":"10.1091\/mbc.E18-10-0650","article-title":"NAD+ consumption by PARP1 in response to DNA damage triggers metabolic shift critical for damaged cell survival","volume":"30","author":"Murata","year":"2019","journal-title":"Mol Biol Cell"},{"key":"10.1016\/j.drudis.2026.104764_b0420","doi-asserted-by":"crossref","first-page":"ra20","DOI":"10.1126\/scisignal.2000902","article-title":"Poly(ADP-ribose) (PAR) binding to apoptosis-inducing factor is critical for PAR polymerase-1-dependent cell death (parthanatos)","volume":"4","author":"Wang","year":"2011","journal-title":"Sci Signal"},{"key":"10.1016\/j.drudis.2026.104764_b0425","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2024.116174","article-title":"Parthanatos: Mechanisms, modulation, and therapeutic prospects in neurodegenerative disease and stroke","volume":"228","author":"Yang","year":"2024","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.drudis.2026.104764_b0430","first-page":"8","article-title":"Age-related decline in hippocampal tyrosine phosphatase PTPRO is a mechanistic factor in chemotherapy-related cognitive impairment","author":"Yao","year":"2023","journal-title":"JCI Insight"},{"key":"10.1016\/j.drudis.2026.104764_b0435","doi-asserted-by":"crossref","first-page":"5441","DOI":"10.1007\/s12035-023-03910-x","article-title":"Wnt3a\/GSK3beta\/beta-catenin signalling modulates doxorubicin-associated memory deficits in breast cancer","volume":"61","author":"Li","year":"2024","journal-title":"Mol Neurobiol"},{"key":"10.1016\/j.drudis.2026.104764_b0440","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.neuro.2024.10.006","article-title":"Neuroprotective effect of empagliflozin against doxorubicin-induced chemobrain in rats: Interplay between SIRT-1\/MuRF-1\/PARP-1\/NLRP3 signaling pathways and enhanced expression of miRNA-34a and LncRNA HOTAIR","volume":"105","author":"Nasr","year":"2024","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.drudis.2026.104764_b0445","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.113686","article-title":"Mechanism of metformin regulation in central nervous system: progression and future perspectives","volume":"156","author":"Cao","year":"2022","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.drudis.2026.104764_b0450","article-title":"Metformin alleviated abeta-induced apoptosis via the suppression of JNK MAPK signaling pathway in cultured hippocampal neurons","volume":"2016","author":"Chen","year":"2016","journal-title":"Biomed Res Int"},{"key":"10.1016\/j.drudis.2026.104764_b0455","doi-asserted-by":"crossref","DOI":"10.1016\/j.expneurol.2024.115129","article-title":"Investigating the effect of metformin on chemobrain: reports from cells to bedside","volume":"385","author":"Leddy","year":"2025","journal-title":"Exp Neurol"},{"key":"10.1016\/j.drudis.2026.104764_b0465","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.cotox.2018.05.002","article-title":"mTOR\/AMPK signaling in the brain: cell metabolism, proteostasis and survival","volume":"8","author":"Garza-Lombo","year":"2018","journal-title":"Curr Opin Toxicol"},{"key":"10.1016\/j.drudis.2026.104764_b0470","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2019.104715","article-title":"Curcumin attenuates cognitive impairment by enhancing autophagy in chemotherapy","volume":"136","author":"Yi","year":"2020","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.drudis.2026.104764_b0475","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/s13058-022-01530-2","article-title":"Effect of physical exercise on cognitive function after chemotherapy in patients with breast cancer: a randomized controlled trial (PAM study)","volume":"24","author":"Koevoets","year":"2022","journal-title":"Breast Cancer Res"},{"key":"10.1016\/j.drudis.2026.104764_b0480","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.bcp.2019.02.010","article-title":"Melatonin protects against methotrexate-induced memory deficit and hippocampal neurogenesis impairment in a rat model","volume":"163","author":"Sirichoat","year":"2019","journal-title":"Biochem Pharmacol"}],"container-title":["Drug Discovery Today"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1359644626001698?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1359644626001698?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T16:21:51Z","timestamp":1790094111000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1359644626001698"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":98,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S1359644626001698"],"URL":"https:\/\/doi.org\/10.1016\/j.drudis.2026.104764","relation":{},"ISSN":["1359-6446"],"issn-type":[{"value":"1359-6446","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeting chemobrain: from experimental models to therapeutic discovery","name":"articletitle","label":"Article Title"},{"value":"Drug Discovery Today","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.drudis.2026.104764","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"104764"}}